Congrats: LCT - gets European patent for neurological disease

[ Follow-Ups ] [ Post Followup ] [ The Islet Foundation Public Message Forum ]

Posted by Ellen on 19:19:42 2010/01/25

Your browser does not support inline frames, or it has been configured incorrectly. If page does not display on your browser, please <a href="http://www.pharmabiz.com/article/detnews.asp?articleid=53702&sectionid=">CLICK HERE</a>. Living Cell Technologies gets European patent for neurological disease product NTCELL - Patents -- -- Tuesday, January 26, 2010 -- Feedback | Helpdesk | Sign up | Login EDITORIAL A PERIOD OF INACTION past editorials ... SERVICES PHARMA TENDERS & PROJECTS Tenders&Enquiries Pharma Projects CORPORATE Company Profiles Corporate Results Corporate X-ray Pharmabiz Studies of Top Companies Indian Cos Approved by Intl Regulatory Agencies US FDA UPDATE US FDA: ANDA - NEW US FDA: Warnings US FDA: Approved NMEs upto November 2008 US FDA: New Approvals US approved Labs with Stem Cell Lines EXPORT & IMPORT Drug Export Procedures Drug Registration Norms for Various Countries Drug Units With WHO GMP Certification Pharma Export Data Import Reg. Update PHARMA LAWS & DOCUMENTS Notifications Pharma Regulations Patent Laws and Amendments Patent Scan Documents New Drug Approvals Notified Prices List of banned FDCs w.e.f. 01.01.2002 List of formulations containing PPA List of FDCs of Rifampicin + Isoniazid LIST OF LABS & GOVT. BODIES Govt Recognised In-House R&D Units AICTE Boards & Committees List of Indian CROs List of CROs (International) Govt & approved labs of India SUBSCRIBE NOW -- SPECIAL FEATURES Features Business of PHARMA MARKETING INTERVIEW 'ISM has found foothold in several countries' Dr T Thirunarayanan, secretary of CTMR past interviews ... function newinfeed(FileName){ window.open(FileName,"View","resizable=yes,scrollbars=yes,height=400,width=700,left=50,top=0"); } Patents Living Cell Technologies gets European patent for neurological disease product NTCELL Monday, January 25, 2010 17:00 IST Sydney, Australia Living Cell Technologies Limited (LCT) announced that it has been granted a European patent for the use of its product NTCELL in the treatment of degenerative neurological conditions such as Parkinson’s disease, Alzheimer’s disease, multiple sclerosis (MS), Huntington’s disease and stroke. LCT’s European patent is based on the technology of preparing NTCELL, which are encapsulated porcine cells of the choroid plexus of the brain. The cells release growth factors and neurotrophins, which are a range of agents that protect and maintain the health of brain cells. NTCELL was designed to protect brain cells from disease and injury and to enhance the natural repair mechanisms in the brain. NTCELL has the potential to restore neural cells and tissue. The porcine choroid plexus cells are encapsulated in a seaweed-derived gel. The encapsulation protects the cells from rejection by the immune system allowing implantation without the need for toxic anti-rejection drugs. Dr Paul Tan, chief executive officer LCT said: “At a time when we are seeing regulatory approvals in Europe and the US for clinical trials with cell-based therapeutics in neurologic disorders, we can expect NTCELL to add significant value to LCT. The granting of this key patent for NTCELL coincides with the publication of LCT’s most recent data on cell therapy for neurological diseases in a leading peer review journal.” Living Cell Technologies (LCT) is developing cell-based products to treat life threatening human diseases. The Company owns a biocertified pig herd that it uses as a source of cells for treating diabetes and neurological disorders. function openWin1(str1) { window.open("/brief/NewsComment.asp?articleid=" + str1,"View","noresize,scrollbar=yes,height=550,width=580,left=70,top=70"); } Post a Comment function openWin(str) { window.open("/article/mail.asp?articleid=" + str +"&sectionid=","View","noresize,scrollbar=yes,height=300,width=400,left=150,top=70"); } -- -- -- -- -- -- The National Pharmaceutical Pricing Authority has fixed / revised the prices in respect of 3 formulation packs vide notifications / orders dated 10.12.2009 NPPA Directory And NPPA Compedium New Drug Approvals Updated upto JULY 2008 US FDA: Approved NMEs upto November 2008 US FDA New Approvals Updated India's Exports of Drugs, pharmaceuticals & fine chemicals (2003-04 to 2008-09) -- -- -- FORTHCOMING EVENTS International Domestic -- CHRONICLE PHARMABIZ SPECIALS Forthcoming Past -- CORPORATE Company Profiles -- Pharma Stocks Executive Diary Pharma People Product Launches PHARMA MART Buyer's Postings Flash Sales Offer Used Equipment Contract Manufacturing Surplus Inventory Home | Archives | Advertise | Contact Us | About Us | Feedback | Helpdesk | Disclaimer Copyright © Saffron Media Pvt. Ltd. Designed & Maintained by Fast Cursor

Click here to visit inline page

Follow Ups:

Post a Followup

[ Follow Ups ] [ Post Followup ] [ The Islet Foundation Public Message Forum ]

Name:
E-Mail: (Optional)
Subject:
Comments:
Link URL: (Optional)
Link Title:
Image URL: (Optional)